Background illustration for clinical trials search

Paid Clinical Trials Minneapolis

Discover 1,005 paid clinical trials in Minneapolis, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Minneapolis MN, Chicago IL, St Louis MO, Detroit MI,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase 1, Recruiting

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

for
Niemann-Pick Type C Disease, GM1 Gangliosidosis,
Location: Minneapolis MN, Rochester MN, Dallas TX, Fairfax VA,
Sponsor: Azafaros B.V.

Sex: All

Age: 4+

Code: NCT07054515

Phase 3, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for
CLL, Chronic Lymphocytic Leukemia
Location: Minneapolis MN, Omaha NE, Grand Rapids MI,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase 3, Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,
Location: Minneapolis MN, Madison WI, Omaha NE, Skokie IL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase 3, Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),
Location: Minneapolis MN, Omaha NE, Louisville KY, Cleveland OH,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

for
Idiopathic Short Stature
Location: Minneapolis MN, Iowa City IA, Ann Arbor MI,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06382155

Phase 2, Recruiting

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

for
Hypoplastic Left Heart Syndrome (HLHS)
Location: Minneapolis MN, Madison WI, Iowa City IA, Milwaukee WI,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0 - 1

Code: NCT02852031

Recruiting

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

for
Focal Segmental Glomerulosclerosis, Minimal Change Disease,
Location: Minneapolis MN, Kansas City MO, Ann Arbor MI,
Sponsor: Travere Therapeutics, Inc.

Sex: All

Age: 1 - 17

Code: NCT05003986

Phase 2, Recruiting

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

for
Chronic Pancreatitis, Exocrine Pancreas Carcinoma,
Location: Minneapolis MN, Iowa City IA, Milwaukee WI, St Louis MO,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0 - 17

Code: NCT06651580

Recruiting

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

for
Status Epilepticus
Location: Minneapolis MN, Iowa City IA, Milwaukee WI, Chicago IL,
Sponsor: University of Virginia

Sex: All

Age: 1+

Code: NCT06907173

Phase 3, Recruiting

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

for
Hypochondroplasia
Location: Minneapolis MN, Chicago IL, Columbia MO,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 0 - 3

Code: NCT07126262

Phase 2, Recruiting

A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

for
Fabry Disease
Location: Minneapolis MN, Cincinnati OH, Pittsburgh PA,
Sponsor: Amicus Therapeutics

Sex: All

Age: 2 - 11

Code: NCT06904261

Phase 3, Recruiting

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

for
Hypochondroplasia
Location: Minneapolis MN, Milwaukee WI, Chicago IL, Columbia MO,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 0 - 15

Code: NCT06212947

Recruiting

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

for
Fragile X Syndrome
Location: Minneapolis MN, Chicago IL, Cincinnati OH, Aurora CO,
Sponsor: Mirum Pharmaceuticals, Inc.

Sex: Male

Age: 13 - 45

Code: NCT07209462

Phase 2, Recruiting

Exploration of the Utility of Dental-dedicated MRI for Dentistry

for
Dental Crowding, Dental Occlusion, Traumatic,
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18+

Code: NCT06948162

Recruiting

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Minneapolis MN, Rochester MN, Marshfield WI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Minneapolis MN, Rochester MN, Chicago IL,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase 2, Recruiting

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Minneapolis MN, Chicago IL, St Louis MO,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 18

Code: NCT06247787

Phase 1, Recruiting

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

for
Solid Tumors
Location: Minneapolis MN, Grand Rapids MI, Fairfax VA,
Sponsor: Adcentrx Therapeutics

Sex: All

Age: 18+

Code: NCT06710379

Phase 1, Recruiting

Adrenoleukodystrophy National Registry Study

for
ALD (Adrenoleukodystrophy), Adrenoleukodystrophy,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0+

Code: NCT03789721

Recruiting